2 Weeks of Citrulline Supplementation on Arterial Function in Postmenopausal Women With Elevated Blood Pressure or Hypertension
Menopause, Hypertension
About this trial
This is an interventional basic science trial for Menopause focused on measuring Endothelial function, Blood flow, Blood pressure, Functional sympatholysis
Eligibility Criteria
Inclusion Criteria: Postmenopausal women (defined as the absence of menstruation for at least 1 year). Resting systolic blood pressure 120-150 mmHg. Between the ages of 50 - 70 years. Sedentary (< 120 minutes of exercise/week). Body mass index of 25 - 39.9 kg/m2. Fasting glucose < 126 mg/dL and HbA1c < 6.5%. Exclusion Criteria: Body mass index ≥ 40 or < 25 kg/m2. Systolic blood pressure > 150 mmHg. Taking more than two antihypertensive medications. Cardiovascular diseases, type I/II diabetes, musculoskeletal disorders, or cancer. Changes in hypertensive medication in the past three months. Began or changed hormone replacement therapy in the past 6 months. Current smoker. Heavy drinking (> 7 alcoholic drinks/week). Participants on beta-blockers or other vasodilatory supplements (nitrates). Incorporated in a weight loss program and/or aerobic or resistance training program.
Sites / Locations
- Texas Tech UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
L-Citrulline
Placebo
L-Citrulline: 6 grams/day divided in 2 equal doses
Microcrystalline cellulose: 8 capsules/day divided into 2 equal doses